HWP
GSK icon

Highline Wealth Partners’s GSK GSK Stock Holding History

Highline Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9K Sell
514
-11
-2% -$582 0.01% 338
2026
Q1 		$29K Hold
525
– – 0.01% 239
2025
Q4 		$25.7K Hold
525
– – 0.01% 215
2025
Q3 		$22.7K Buy
525
+27
+5% +$1.05K 0.01% 253
2025
Q2 		$19.1K Buy
498
+23
+5% +$879 0.01% 232
2025
Q1 		$18.4K Buy
475
+428
+911% +$15.7K 0.01% 216
2024
Q4 		$1.59K Buy
47
+7
+18% +$252 ﹤0.01% 481
2024
Q3 		$1.64K Sell
40
-54
-57% -$2.21K ﹤0.01% 468
2024
Q2 		$3.62K Buy
+94
New +$3.95K ﹤0.01% 317
2023
Q4 		– Sell
-20
Closed -$718 – 420
2023
Q3 		$725 Buy
+20
New +$710 ﹤0.01% 332

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Highline Wealth Partners's GSK Position: Q2 2026 in Review

Highline Wealth Partners reduced its GSK (GSK) stake by 2.1% in Q2 2026, selling an estimated $582 and leaving 514 shares worth $26.9K. The position accounts for 0.01% of the portfolio, ranked #338.

Highline Wealth Partners first reported a position in GSK in Q3 2023 and has held it in 10 quarters since. The position peaked at $29K in Q1 2026. 214 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Highline Wealth Partners held 514 shares of GSK worth $26.9K as of Q2 2026.
  • Highline Wealth Partners sold 11 GSK shares in Q2 2026, an estimated $582.
  • GSK made up 0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #338 holding.
  • Highline Wealth Partners first reported a position in GSK in Q3 2023 and has held it in 10 quarters since.
  • Highline Wealth Partners's GSK position peaked at $29K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.